Acute effect of percutaneous MitraClip therapy in patients with haemodynamic decompensation

European Journal of Heart Failure

Volumn 14, Issue 8, 2012, Pages 939-945

  Biner, Simon ^a,b   Siegel, Robert J ^a   Feldman, Ted ^c   Rafique, Asim M ^a   Trento, Alfredo ^a   Whitlow, Patrick ^d   Rogers, Jason ^e   Moon, Marc ^f   Lindman, Brian ^f   Zajarias, Alan ^f   Glower, Donald ^g   Kar, Saibal ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c EVANSTON HOSPITAL   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Haemodynamics; MitraClip; Mitral regurgitation

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE SEVERITY; HEART FAILURE; HEART HEMODYNAMICS; HEART INDEX; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART OUTPUT; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE;

ACUTE DISEASE; AGED; CARDIAC OUTPUT; FEASIBILITY STUDIES; FEMALE; HEALTH STATUS INDICATORS; HEART FAILURE; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; MALE; STATISTICS AS TOPIC; ULTRASONOGRAPHY, DOPPLER;

EID: 84864446462     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfs069     Document Type: Article

References (19)

1. Feldman T, Foster E, Glower DG, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L; EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395-1406.
2. Franzen O, van der Heyden J, Schlüter M, Baldus S, Schillinger W, Butter C, Hoffmann R, Corti R, Pedrazzini G, Swaans MJ, Neuss M, Grünenfelder J, Eulenburg C, Reichenspurner H, Meinertz T, Auricchio A. MitraClip therapy in patients with end-stage systolic heart failure. Eur J Heart Fail 2011;13:569-576.
3. Schillinger W, Athanasiou T, Weicken N, Berg L, Tichelbäcker T, Puls M, Hünlich M, Wachter R, Helms HJ, Seipelt R, Schöndube FA, Hasenfuss G. Impact of the learning curve on outcomes after percutaneous mitral valve repair with MitraClip and lessons learned after the first 75 consecutive patients. Eur J Heart Fail 2011;13:1331-1339.
4. Auricchio A, Schillinger W, Meyer S, Maisano F, Hoffmann R, Ussia GP, Pedrazzini G, van der Heyden J, Fratini S, Klersy C, Komtebedde J, Franzen O. on behalf of the PERMIT-CARE investigators. Correction of mitral regurgitation in non-responders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol 2011;58: 2183-2189.
5. Siegel RJ, Biner S, Rafique AM, Rinaldi M, Lim S, Fail P, Hermiller J, Smalling R, Whitlow PL, Herrmann HC, Foster E, Feldman T, Glower D, Kar S; EVEREST Investigators. The acute hemodynamic effects of MitraClip therapy. J Am Coll Cardiol 2011;57:1658-1665.
6. Gaemperli O, Moccetti M, Surder D, Biaggi P, Hurlimann D, Kretschmar O, Buehler I, Bettex D, Felix C, Luscher TF, Falk V, Grunenfelder J, Corti R. Acute haemodynamic changes after percutaneous mitral valve repair: relation to mid-term outcomes. Heart 2012;98:126-132.
7. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;52:e1-142.
8. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A; Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-268.
9. Tribouilloy CM, Enriquez-Sarano M, Schaff HV, Orszulak TA, Bailey KR, Tajil AJ, Frye RL. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation 1999;99:400-405.
10. Ghoreishi M, Evans CF, DeFilippi CR, Hobbs G, Young CA, Griffith BP, Gammie JS. Pulmonary hypertension adversely affects short-and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery. J Thorac Cardiovasc Surg 2011;142:1439-1452.
11. Feldman T, Wasserman HS, Herrmann HC, Gray W, Block PC, Whitlow P, St Goar F, Rodriguez L, Silvestry F, Schwartz A, Sanborn TA, Condado JA, Foster E. Percutaneous mitral valve repair using the edge-to-edge technique: sixmonth results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 2005;46: 2134-2140.
12. Glover D, Young N, Alexander J, Gangahar D, Skipper E, Cleveland J, Trento A, Feldman T, on behalf of the EVEREST II investigators. EVEREST II randomized clinical trial: a clinical assessment of anatomical predictors of de novo mitral valve replacement or following MitraClip procedure. J Am Coll Cardiol 2010;56;B24.
13. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ; American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with twodimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16: 777-802.
14. Ganz W, Donoso R, Marcus HS, Forrester JS, Swan HJ. A new technique for measurement of cardiac output by thermodilution in man. Am J Cardiol 1971; 27:392-396.
15. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson LJ. Harrison's Principles of Internal Medicine. 16th ed. New Yok: McGraw-Hill; 2005.
16. Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993;73:413-467.
17. Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, Johnson BD, Redfield MM. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol 2010;56:845-854.
18. Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Détaint D, Vanoverschelde JL, Butchart EG, Ravaud P, Vahanian A. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007;28:1358-1365.
19. Enriquez-Sarano M, Loulmet DF, Burkhoff D. The conundrum of functional mitral regurgitation in chronic heart failure. J Am Coll Cardiol 2008;51: 487-489.